GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ANG Lifesciences India Ltd (BOM:540694) » Definitions » EV-to-Revenue

ANG Lifesciences India (BOM:540694) EV-to-Revenue : 0.81 (As of Jun. 08, 2024)


View and export this data going back to 2017. Start your Free Trial

What is ANG Lifesciences India EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, ANG Lifesciences India's enterprise value is ₹1,201 Mil. ANG Lifesciences India's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1,476 Mil. Therefore, ANG Lifesciences India's EV-to-Revenue for today is 0.81.

The historical rank and industry rank for ANG Lifesciences India's EV-to-Revenue or its related term are showing as below:

BOM:540694' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.3   Med: 0.63   Max: 2.49
Current: 0.81

During the past 11 years, the highest EV-to-Revenue of ANG Lifesciences India was 2.49. The lowest was 0.30. And the median was 0.63.

BOM:540694's EV-to-Revenue is ranked better than
83.43% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 2.255 vs BOM:540694: 0.81

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-08), ANG Lifesciences India's stock price is ₹51.72. ANG Lifesciences India's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹104.94. Therefore, ANG Lifesciences India's PS Ratio for today is 0.49.


ANG Lifesciences India EV-to-Revenue Historical Data

The historical data trend for ANG Lifesciences India's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANG Lifesciences India EV-to-Revenue Chart

ANG Lifesciences India Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.28 0.57 0.89 0.75

ANG Lifesciences India Quarterly Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 0.75 0.44 0.83 0.61

Competitive Comparison of ANG Lifesciences India's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, ANG Lifesciences India's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ANG Lifesciences India's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ANG Lifesciences India's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where ANG Lifesciences India's EV-to-Revenue falls into.



ANG Lifesciences India EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

ANG Lifesciences India's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1201.110/1475.94
=0.81

ANG Lifesciences India's current Enterprise Value is ₹1,201 Mil.
ANG Lifesciences India's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,476 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ANG Lifesciences India  (BOM:540694) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

ANG Lifesciences India's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=51.72/104.937
=0.49

ANG Lifesciences India's share price for today is ₹51.72.
ANG Lifesciences India's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹104.94.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ANG Lifesciences India EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of ANG Lifesciences India's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


ANG Lifesciences India (BOM:540694) Business Description

Traded in Other Exchanges
N/A
Address
Ranjit Avenue, B-Block, Darbara Complex, SCO 113, First Floor, District Shopping Complex, Amritsar, PB, IND, 143001
ANG Lifesciences India Ltd is an India-based engaged in the manufacturing of finished pharmaceutical formulations in the form of dry powder for injections. Geographically, the company carries out sales within India, as well as outside India; generating the majority of revenue from the sales of injections within India.

ANG Lifesciences India (BOM:540694) Headlines

No Headlines